The FDA has expanded the indication for afatinib (Gilotrif) to include the treatment of patients with metastatic non–small cell lung cancer (NSCLC) whose tumors have uncommon EGFR alterations in L861Q, G719X, and/or S768I. onclive.com/web-exclusives/... This FDA approval was based on trials studying the response to afatinib in patients whose tumors had mutations in EGFR. The results help advance our understanding of the efficacy of afatinib and also highlight the importance of tumor testing of patients with lung cancer.
News from the FDA: the indication for ... - Lung Cancer Support
News from the FDA: the indication for a drug targeting EGFR is expanded to uncommon mutations
Written by
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
scifiknitterBlogger
More options are good news! This is based on a small subset of patients, but response rates and duration of efficacy were're both compelling.
Not what you're looking for?
You may also like...
First Targeted Adjuvant Therapy for EGFR Non Small Cell Lung Cancer (stage IB-IIIA)
On December 18th, 2020, the Food and Drug Administration (FDA) approved Tagrisso (osimertinib) for...
FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression
On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
An immunotherapy now approved for first-line treatment
Late yesterday, the FDA approved Keytruda (an immunotherapy) as a first-line treatment for patients...
Gilotrif/Afatinib
52 years old and have stage 4 lung cancer. I am EGFR positive and have been taking gilotrif/...
Study presented at the European Society for Medical Oncology (ESMO) Congress may mean a new way to treat patients with stage 3 lung cancer
This past week, results of some key studies were presented at a major meeting in Spain. One study,...
Farewell to our dear friend Anita 
EGFR mutations on exon 20 and exon 21
C T Scan results
Introduction
Devastated! my Non-Small Cell Lung Cancer Transformed into Small Cell Lung Cancer
